DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Arguments
Applicant's arguments filed 08/05/2026 have been fully considered but they are not persuasive.
The Applicant relies on the USPTO guidance related to Claim 1 of the Example 34 of December 2016 Subject Matter Eligibility Examples to argue Claims 1, 12, and 22 of the instant application are at least directed to patentable subject matter for (See pages 9-13 of the Applicant’s Arguments):
1) Clearly being directed to an improvement in the computer technology of filtering;
2) Requiring a claimed arrangement of elements that results in an improvement in the technology of filtering content, which is specifically identified in the specification when using other information location services that do not implement the claimed filtering technology; and
3) Being directed to a practical application that that is not well- understood, routine or conventional activity, as explained in the specification.
However, the Examiner believes Example 34 claims are eligible while the instant ones are not for the following reasons:
It is the combination of additional elements in Example 34 that amount to significantly more than the abstract idea in Step 2B.
Claim 1 in Example 34 recites the additional elements of: 1) controlled access network accounts, 2) a local client computer to generate network access requests for the controlled access network accounts, 3) an Internet computer network, and 4) a remote ISP server coupled to the client computer and the Internet computer network. The USPTO states “an inventive concept can be found in the unconventional and non‐generic combination of known elements, and more specifically “the installation of a filtering tool at a specific location, remote from the end‐users, with customizable filtering features specific to each end user” where the filtering tool at the ISP is able to “identify individual accounts that communicate with the ISP server, and to associate a request for Internet content with a specific individual account.” The Federal Circuit also determined that the claimed arrangement of elements in the system results in an improvement in the technology of filtering content on the Internet, because it offers “both the benefits of a filter on the local computer, and the benefits of a filter on the ISP server” (page 4 of Example 34).
Claim 1 of the instant specification recites the additional elements of 1) a diabetes medical device and 2) a mobile device. However, critically, it is not the arrangement of these devices that is the asserted improvement in technology—rather, it is the filtering itself, wherein the filtering is based on a relative location of the mobile device, that is an improvement over prior art.
Filtering a dataset of diabetes medical supplies facilities based on 1) a relative location of a mobile device and 2) the detection that the supply of the diabetes medical product is below the predefined threshold is itself an abstract idea that cannot overcome Step 2A, Prong Two or Step 2B.
The Office concludes that “filtering content is according to the court a “method of organizing human behavior” that is similar to other concepts that have been identified as abstract by the courts” as stated in Example 34 (page 3). Filtering content, even based on a relative location of the mobile device, is mental process. An improvement in the abstract idea itself (e.g. a recited fundamental economic concept) is not an improvement in technology. In other words, the improvement in technology cannot come from improvement in the abstract idea. See MPEP 2106.05(a).
For these reasons, the rejection of the claims under 35 U.S.C. § 101 is maintained.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Claims 1-25 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim(s) as a whole, considering all claim elements both individually and in combination, do not amount to significantly more than an abstract idea. A streamlined analysis of claim 1 follows.
Regarding Claim 1, the claim recites a method. Thus, the claim is directed to a process, which is one of the statutory categories of invention (Step 1).
The claim is then analyzed to determine whether it is directed to any judicial exception (Step 2A, Prong One). The following limitations set forth a judicial exception:
detecting, based on information from a diabetes medical device, that a supply of a diabetes medical product associated with the diabetes medical device is below a predefined threshold
filtering, based on a relative location of a mobile device and the detection that the supply of the diabetes medical product is below the predefined threshold, a dataset of diabetes medical supplies facilities to identify a subset of the diabetes medical supplies facilities within a predefined distance of the location of the mobile device
accessing at least one datastore associated with at least one diabetes medical supplies facility of the subset of the diabetes medical supplies facilities within the predefined distance of the location of the mobile device to determine an inventory of the diabetes medical product at the at least one diabetes medical supplies facility
filtering, based on the access to the at least one datastore, the subset of the diabetes medical supplies facilities to identify one or more diabetes medical supplies facilities of the subset of the diabetes medical supplies facilities having an amount of the diabetes medical product indicated in the inventory
displaying...the amount of the diabetes medical product indicated in the inventory at each of the one or more diabetes medical supplies facilities
These limitations describe a mathematical calculation and/or a mental process as the skilled artisan is capable of performing the recited limitations and making a mental assessment thereafter. Examiner also notes that nothing from the claims suggest that the limitations cannot be practically performed by a human with the aid of a pen and paper, or using a generic computer as a tool to perform mathematical calculations and/or mental process steps in real time. Examiner also notes that nothing from the claims suggests an undue level of complexity that the mathematical calculations and/or the mental process steps cannot be practically performed by a human with the aid of a pen and paper, or using a generic computer as a tool to perform mathematical calculations and/or mental process steps.
For example:
The plain meaning of the limitation “detecting, based on information from a diabetes medical device, that a supply of a diabetes medical product associated with the diabetes medical device is below a predefined threshold” includes mental processes that can be performed in the human mind by observations, evaluations, judgments, and opinions, or by a human with the aid of a pen and paper, or using a generic computer as a tool to perform these mental process steps in real time.
The plain meaning of the limitation “filtering, based on a relative location of a mobile device and the detection that the supply of the diabetes medical product is below the predefined threshold, a dataset of diabetes medical supplies facilities to identify a subset of the diabetes medical supplies facilities within a predefined distance of the location of the mobile device” includes mental processes that can be performed in the human mind by observations, evaluations, judgments, and opinions, or by a human with the aid of a pen and paper, or using a generic computer as a tool to perform these mental process steps in real time.
A human is capable of manually/mentally accessing at least one datastore associated with at least one diabetes medical supplies facility of the subset of the diabetes medical supplies facilities within the predefined distance of the location of the mobile device to “determine an inventory of the diabetes medical product at the at least one diabetes medical supplies facility”, which includes mental processes that can be performed in the human mind by observations, evaluations, judgments, and opinions, or by a human with the aid of a pen and paper, or using a generic computer as a tool to perform these mental process steps in real time.
The plain meaning of the limitation “filtering, based on the access to the at least one datastore, the subset of the diabetes medical supplies facilities to identify one or more diabetes medical supplies facilities of the subset of the diabetes medical supplies facilities having an amount of the diabetes medical product indicated in the inventory” includes mental processes that can be performed in the human mind by observations, evaluations, judgments, and opinions, or by a human with the aid of a pen and paper, or using a generic computer as a tool to perform these mental process steps in real time.
A human is capable of manually/mentally displaying the amount of the diabetes medical product indicated in the inventory at each of the one or more diabetes medical supplies facilities e.g. by writing, texting, or emailing said information to be displayed on paper or a generic computer screen.
Next, the claim as a whole is analyzed to determine whether any element, or combination of elements, integrates the identified judicial exception into a practical application (Step 2A, Prong Two).
The following limitations amount to insignificant extra-solution activity to the judicial exception, e.g. mere data gathering. See MPEP 2106.05(g).
...based on information from a diabetes medical device...
The following limitations amount to a recitation of the words "apply it" (or an equivalent) and/or nothing more than mere instructions to implement the abstract idea on a generic computer. See MPEP 2106.05(f).
displaying on the mobile device the amount of the diabetes medical product indicated in the inventory at each of the one or more diabetes medical supplies facilities
Therefore, these additional limitations do not integrate the judicial exception into a practical application.
Next, the claim as a whole is analyzed to determine whether any element, or combination of elements, amounts to significantly more than the identified judicial exception (Step 2B):
The following limitations do not amount to significantly more than the abstract idea for substantially similar reasons applied in Step 2A, Prong Two.
...based on information from a diabetes medical device...
displaying on the mobile device the amount of the diabetes medical product indicated in the inventory at each of the one or more diabetes medical supplies facilities
The following limitations is/are considered to be well-understood, routine, and conventional (WURC).
The mobile device is considered to be well-understood, routine, and conventional based on statement from the applicant's specification filed 06/24/2024 ([0024]).
The diabetes medical device is considered to be well-understood, routine, and conventional based on statement from the applicant's specification filed 06/24/2024 ([0069]).
Independent Claim 12 is also not patent eligible for substantially similar reasons as it recites the same abstract idea(s) and additional element(s) as Claim 1 but as an apparatus-type claim.
Independent Claim 22 is also not patent eligible for substantially similar reasons as it recites the same abstract idea(s) and additional element(s) as Claim 1 but as an apparatus-type claim.
Dependent Claim 2 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea (“wherein the method further comprises receiving an indication from the insulin pump or the smart insulin pen that the insulin is below the predefined threshold”), and recites limitations that do not integrate the claims into a practical application and do not recite significantly more than the identified abstract idea (“wherein the diabetes medical device comprises an insulin pump or a smart insulin pen, and wherein the diabetes medical product is insulin”).
Dependent Claim 3 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea (“wherein the method further comprises receiving an indication from the BG meter that a number associated with the test strip is below the predefined threshold”), recites limitations that do not integrate the claims into a practical application (“wherein the diabetes medical device comprises a blood- glucose (BG) meter, wherein the diabetes medical product is a test strip”), and does not recite significantly more than the identified abstract idea (“wherein the diabetes medical device comprises a blood- glucose (BG) meter, wherein the diabetes medical product is a test strip”).
Dependent Claim 4 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 5 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 6 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 7 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 8 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 9 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 10 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 11 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 13 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea (“receive an indication from the insulin pump or the smart insulin pen that the insulin is below the predefined threshold”), recites limitations that do not integrate the claims into a practical application (“wherein the diabetes medical device comprises an insulin pump or a smart insulin pen, and wherein the diabetes medical product is insulin, wherein the instructions are further configured to cause the at least one processor to...”), and does not recite significantly more than the identified abstract idea (“wherein the diabetes medical device comprises an insulin pump or a smart insulin pen, and wherein the diabetes medical product is insulin, wherein the instructions are further configured to cause the at least one processor to...”).
Dependent Claim 14 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea (“receive an indication from the BG meter that a number associated with the test strip is below the predefined threshold”), recites limitations that do not integrate the claims into a practical application (“wherein the diabetes medical device comprises a blood-glucose (BG) meter, wherein the diabetes medical product is a test strip, wherein the instructions are further configured to cause the at least one processor to...”), and does not recite significantly more than the identified abstract idea (“wherein the diabetes medical device comprises a blood-glucose (BG) meter, wherein the diabetes medical product is a test strip, wherein the instructions are further configured to cause the at least one processor to...”).
Dependent Claim 15 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 16 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 17 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 18 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 19 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 20 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 21 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 23 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea (“receive an indication from the insulin pump or the smart insulin pen that the insulin is below the predefined threshold”), recites limitations that do not integrate the claims into a practical application (“wherein the diabetes medical device comprises an insulin pump or a smart insulin pen, and wherein the diabetes medical product is insulin, wherein the processor is further configured to...”), and does not recite significantly more than the identified abstract idea (“wherein the diabetes medical device comprises an insulin pump or a smart insulin pen, and wherein the diabetes medical product is insulin, wherein the processor is further configured to...”).
Dependent Claim 24 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Dependent Claim 25 also fails to add subject matter qualifying as significantly more to the abstract independent claims as it merely further limits the abstract idea.
Therefore, Claims 1-25 are not patent eligible under 35 U.S.C. § 101.
Examiner’s Note
The Examiner notes Claims 1-25 are not currently rejected under prior art.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
See Ather (US 20170256014 A1).
See Booker et al (US 20190147880 A1) (Fig. 7C, [0226]; [0247]).
See Hill (US 9282161 B1) (2:42-48)
See Koch et al (US 20200279191 A1) (“all merchants within the delivery logistics system may be filtered based on customer location to determine the available merchants. For example, only merchants within a predetermined radius of the customer may be determined to be available merchants and scored for presentation to the customer during a browsing session”, [0219]).
See Mawji et al (US 20170235792 A1) (“The current location of the user device may be compared with the current location of the entity to determine whether the current location of the entity is within a threshold geography. The database search may also filter search results by current location first, and then further filter the results by trust score”, [0016]).
Bryant et al (US 20220189614 A1) discloses relevant subject matter but does not qualify as prior art.
Siegel (US 20210065862 A1) discloses relevant subject matter (e.g. Fig. 1, Fig. 5, [0067], [0079]) but does not qualify as prior art.
Bhow (US 11893623 B1) discloses relevant subject matter but does not qualify as prior art (US 11893623 B1).
Lopez (US 20160027089 A1) discloses filtering, (Steps 303, 310, and 312, Fig. 3) based on a relative location of a mobile device (Claims 6 and 18) and the detection that the supply of the medical product is below the predefined threshold (Step 201, Fig. 2), a dataset of medical supplies facilities to identify a subset of the medical supplies facilities within a predefined distance of the location of the mobile device (Step 312, Fig. 3). However, Lopez does not disclose the medical product to be a diabetes medical product or displaying on the mobile device the amount of the diabetes medical product indicated in the inventory at each of the one or more diabetes medical supplies facilities.
The Examiner notes there is no obvious combination of these references that can be made with reasonable motivation(s) to disclose the entirety of the independent claims and therefore, the claimed invention
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JONATHAN EPHRAIM COOPER whose telephone number is (571)272-2860. The examiner can normally be reached Monday-Friday 7:30AM-5:30PM EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jacqueline Cheng can be reached at (571) 272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JONATHAN E. COOPER/ Examiner, Art Unit 3791
/JACQUELINE CHENG/ Supervisory Patent Examiner, Art Unit 3791